Bayer is deepening its phygital push in Indian agriculture as its FarmRise app hits 5 million users. The expanded offering blends AI-powered advisory with satellite-based insights focused on risk protection, alongside digital marketplaces. The goal: help farmers make faster, smarter decisions that support productivity and sustainability in day to day operations.
Bayer plans to acquire Perfuse Therapeutics in a deal worth up to $2.45 billion, aiming to strengthen its eye care pipeline. The purchase includes PER-001, currently in clinical trials and targeting glaucoma and diabetic retinopathy, two major causes of vision loss. The move signals Bayer’s push to expand treatment options through late-stage development.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
In an exclusive interview, Bayer’s global head of pharmaceuticals, Stefan Oelrich, said the company will intensify its push for tiered pricing in India. The move is linked to Bayer’s “tailormade India” portfolio and its broader investment plans in innovation, aiming to balance affordability with business sustainability.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
